Inhibitors of C5 complement enhance vaccinia virus oncolysis.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 6, p. 342, doi. 10.1038/cgt.2013.26
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2013 AND VI 20 AND IP 6
Results: 7
1
2
Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 6, p. 366, doi. 10.1038/cgt.2013.29
- By:
- Publication type:
- Article
3
Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 6, p. 375, doi. 10.1038/cgt.2013.30
- By:
- Publication type:
- Article
4
An HDAC inhibitor enhances cancer therapeutic efficiency of RNA polymerase III promoter-driven IDO shRNA.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 6, p. 351, doi. 10.1038/cgt.2013.27
- By:
- Publication type:
- Article
5
A triple suicide gene strategy that improves therapeutic effects and incorporates multimodality molecular imaging for monitoring gene functions.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 6, p. 358, doi. 10.1038/cgt.2013.28
- By:
- Publication type:
- Article
6
Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 6, p. 336, doi. 10.1038/cgt.2013.25
- By:
- Publication type:
- Article
7
Aerosol delivery of eukaryotic translation initiation factor 4E-binding protein 1 effectively suppresses lung tumorigenesis in K-ras<sup>LA1</sup> mice.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 6, p. 331, doi. 10.1038/cgt.2013.24
- By:
- Publication type:
- Article